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Summary 
The immune system is critically dependent on the ability to recognize transformed, infected, or 
otherwise stressed cells. In this regard, the NKG2D/NKG2D-ligand interaction represents an 
important sensing mechanism. NKG2D is an activating receptor expressed by several effector 
cells of the immune system, whereas NKG2D-ligands are up-regulated on the surface of 
abnormal cells. The present thesis addresses the regulation of NKG2D-ligand expression on 
cancer cells following stress (HDAC-inhibitor treatment) or infection (VSV), as well as the 
regulation of NKG2D expression on CD4+ T-cells specific for HCMV. 
Calcium was found to be critical for cell surface expression of the NKG2D-ligands MICA/B and 
ULBP2 on cancer cells upon HDAC-inhibitor treatment. However, the calcium-dependency of 
MICA/B and ULBP2 was not homogenous, suggesting distinct modes of regulation. The 
calcium-regulated proteins calmodulin and calpain were found not to be important for HDAC-
inhibitor induced NKG2D-ligand expression. Furthermore, cell surface binding of the calcium-
regulating protein galectin-1 was not involved. HDAC-inhibitor treatment of cancer cells 
increased the secretion of soluble ULBP2 and/or galectin-1, both of which can have inhibitory 
effects on immune cell functions. 
Infection with the oncolytic virus VSV induced a robust expression of MICA at the mRNA level. 
However, the subsequent cell surface expression of this ligand was potently hindered, suggesting 
the involvement of an immune evasion mechanism. The VSV mediated downmodulation of 
NKG2D-ligand expression did not involve apoptosis. Furthermore, an M protein-mediated 
blockade of nucleocytoplasmic mRNA transport or an inhibition of protein synthesis was found 
not to be pivotal.  
NKG2D cell surface expression was analyzed on CD4+ T-cells following stimulation with 
different pathogens and was solely observed on CD4+ T-cells specific for HCMV. The HCMV-
specific NKG2D+ CD4+ T-cells possessed a higher differentiated phenotype than the NKG2D– 
CD4+ T-cells. Furthermore, the ability to express NKG2D was reflected by a change in the 
activation/differentiation status of the CD4+ T-cells. A correlation between CD94 and NKG2D 
expression was observed, but was not important for NKG2D cell surface expression or signaling. 
In addition, NKG2D was found to be recycled at the cell surface by activated CD4+ T-cells, in 
contrast to de novo production in resting cells. 
 
